Renal - Theranova
Device
BAXTER HEALTHCARE
Total Payments
$2.4M
Transactions
332
Doctors
12
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5,300 | 8 | 4 |
| 2023 | $16.41 | 1 | 1 |
| 2022 | $63.99 | 1 | 1 |
| 2020 | $27,345 | 3 | 2 |
| 2019 | $383,462 | 68 | 3 |
| 2018 | $2.0M | 250 | 5 |
| 2017 | $4,991 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 271 | 96.6% |
| Consulting Fee | $65,055 | 19 | 2.7% |
| Travel and Lodging | $16,293 | 14 | 0.7% |
| Food and Beverage | $917.99 | 27 | 0.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $469.39 | 1 | 0.0% |
Payments by Type
Research
$2.3M
271 transactions
General
$82,736
61 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Theranova 400 Dialyzer In End Stage Renal Disease -ESRD- Patients - 7905001 | Baxter Healthcare | $1.2M | 0 |
| Theranova 400 Dialyzer In End Stage Renal Disease -ESRD- Patients - 7905001 | BAXTER HEALTHCARE | $1.1M | 0 |
| A Multi-Center, Prospective, Randomized, Controlled, Open-label, Parallel Study to Evaluate the Safety and Efficacy of the Theranova 400 Dialyzer In End Stage Renal Disease -ESRD- Patients | Baxter Healthcare | $27,316 | 0 |
Top Doctors Receiving Payments for Renal - Theranova
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Nashville, TN | $2.3M | 271 |
| , MD | Nephrology | Burr Ridge, IL | $38,740 | 23 |
| , MD | Nephrology | Winston Salem, NC | $18,478 | 12 |
| , MD | Internal Medicine | San Francisco, CA | $18,159 | 12 |
| , MD, PHD | Nephrology | Nashville, TN | $2,720 | 2 |
| Mitchell Rosner | Nephrology | Charlottesville, VA | $2,371 | 3 |
| , M.D | Pediatric Nephrology | Madison, WI | $1,671 | 3 |
| , M.D | Nephrology | Torrance, CA | $469.39 | 1 |
| , MD | Nephrology | Jonesboro, AR | $63.99 | 1 |
| , FNP | Family | Elizabeth, NJ | $18.03 | 1 |
| , MD | Nephrology | Odessa, TX | $16.41 | 1 |
| , MD | Internal Medicine | Newburgh, NY | $14.45 | 1 |
| , MD | Nephrology | Poughkeepsie, NY | $14.45 | 1 |
Ad
Manufacturing Companies
- Baxter Healthcare $1.2M
- BAXTER HEALTHCARE $1.2M
Product Information
- Type Device
- Total Payments $2.4M
- Total Doctors 12
- Transactions 332
About Renal - Theranova
Renal - Theranova is a device associated with $2.4M in payments to 12 healthcare providers, recorded across 332 transactions in the CMS Open Payments database. The primary manufacturer is BAXTER HEALTHCARE.
Payment data is available from 2017 to 2024. In 2024, $5,300 was paid across 8 transactions to 4 doctors.
The most common payment nature for Renal - Theranova is "Unspecified" ($2.3M, 96.6% of total).
Renal - Theranova is associated with 3 research studies, including "Theranova 400 Dialyzer In End Stage Renal Disease -ESRD- Patients - 7905001" ($1.2M).